Leading Expert On U.S. Health Reform Gives His Two Cents
Paul Keckley noted that things may get worse before they get better in the healthcare and lifescience industry in the United States.
Paul Keckley noted that things may get worse before they get better in the healthcare and lifescience industry in the United States.
Inovio Pharmaceuticals reported Friday the positive long-term effects of its VGX-3100 vaccine, designed to treat cervical dysplasia and cancer caused by the human papillomavirus, or HPV.
GSV Capital Founder & CEO Michael Moe interviewed by OneMedRadio. GSV raised $50 million in an IPO in May 2011 to invest in emerging technology companies.
Swiss drug maker Novartis said results from a phase three study remarkably improved lung function in a similar way to a rival drug.
The fundamental concept of cloud computing dates back to the 1960s, when John McCarthy was quoted as saying “computation may someday be organized as public utility.”
There is no excerpt because this is a protected post.
For many emerging companies, one of their largest financial investments and most important strategic decisions is their approach to sales and distribution.
After bringing his clinical research software company back from near bankruptcy to steady profitability in 2010, CEO Larry Birch is going on the offensive.
NeoStem announced Monday that its subsidiary, Suzhou Eyre Pharmaceuticals, has received approval for its sixth production line.
e-Zassi is the medical device industry’s first subscription-based, decision support software and technology marketplace.
Copyright © 2025 | WordPress Theme by MH Themes